Citations

Clear

382 citation(s) found for "Li, Man".

Effects of Type 2 Diabetes on Insulin Secretion, Insulin Action, Glucose Effectiveness, and Postprandial Glucose Metabolism
Basu, Ananda , Man, Chiara Dalla , Basu, Rita , Toffolo, Gianna , Rizza, Robert A., Cobelli, Claudio , Dalla Man, Chiara

Mayo Clinic

Diabetes Care | February 7, 2009 | Volume: 32 | Issue: 5 | Pages: 866-872

10.2337/dc08-1826 | PMID 19196896 Get It

OBJECTIVE In this study, we sought to determine whether postprandial insulin secretion, insulin action, glucose effectiveness, and glucose turnover were abnormal in type 2 diabetes. RESEARCH DESIGN AND METHODS Fourteen subjects with type 2 diabetes and 11 nondiabetic subjects matched for age, weight, and BMI underwent a mixed-meal test using the triple-tracer technique. Indexes of insulin secretion, insulin action, and glucose effectiveness were assessed using the oral “minimal” and C-peptide models. RESULTS Fasting and postprandial glucose concentrations were higher in the diabetic than nondiabetic subjects. Although peak insulin secretion was delayed (P < 0.001) and lower (P < 0.05) in type 2 diabetes, the integrated total postprandial insulin response did not differ between groups. Insulin action, insulin secretion, disposition indexes, and glucose effectiveness all were lower (P < 0.05) in diabetic than in nondiabetic subjects. Whereas the rate of meal glucose appearance did not differ between groups, the percent suppression of endogenous glucose production (EGP) was slightly delayed and the increment in glucose disappearance was substantially lower (P < 0.01) in diabetic subjects during the first 3 h after meal ingestion. Together, these defects resulted in an excessive rise in postprandial glucose concentrations in the diabetic subjects. CONCLUSIONS When measured using methods that avoid non–steady-state error, the rate of appearance of ingested glucose was normal and suppression of EGP was only minimally impaired. However, when considered in light of the prevailing glucose concentration, both were abnormal. In contrast, rates of postprandial glucose disappearance were substantially decreased due to defects in insulin secretion, insulin action, and glucose effectiveness.
Dipeptidyl Peptidase-4 Inhibition by Vildagliptin and the Effect on Insulin Secretion and Action in Response to Meal Ingestion in Type 2 Diabetes
Man, Chiara Dalla , Bock, Gerlies, Giesler, Paula D., Serra, Denise , Saylan, Monica Ligueros, Foley, James E. , Camilleri, Michael , Toffolo, Gianna , Rizza, Robert A., Treiber, Gerlies , Cobelli, Claudio , Vella, Adrian , Dalla Man, Chiara

Mayo Clinic

Diabetes Care | October 18, 2008 | Volume: 32 | Issue: 1 | Pages: 14-18

10.2337/dc08-1512 | PMID 18931099 Get It

OBJECTIVE—The purpose of this study was to determine the mechanism by which dipeptidyl peptidase-4 inhibitors lower postprandial glucose concentrations. RESEARCH DESIGN AND METHODS—We measured insulin secretion and action as well as glucose effectiveness in 14 subjects with type 2 diabetes who received vildagliptin (50 mg b.i.d.) or placebo for 10 days in random order separated by a 3-week washout. On day 9 of each period, subjects ate a mixed meal. Insulin sensitivity (SI), glucose effectiveness, and β-cell responsivity indexes were estimated using the oral glucose and C-peptide minimal models. At 300 min 0.02 unit/kg insulin was administered intravenously. RESULTS—Vildagliptin reduced postprandial glucose concentrations (905 ± 94 vs. 1,008 ± 104 mmol/6 h, P = 0.02). Vildagliptin did not alter net SI (7.71 ± 1.28 vs. 6.41 ± 0.84 10−4 dl · kg−1 · min−1 · μU−1 · ml−1, P = 0.13) or glucose effectiveness (0.019 ± 0.002 vs. 0.018 ± 0.002 dl · kg−1 · min−1, P = 0.65). However, the net β-cell responsivity index was increased (35.7 ± 5.2 vs. 28.9 ± 5.2 10−9 min−1, P = 0.03) as was total disposition index (381 ± 48 vs. 261 ± 35 10−14 dl · kg−1 · min−2 · pmol−1 · l−1, P = 0.006). Vildagliptin lowered postprandial glucagon concentrations (27.0 ± 1.1 vs. 29.7 ± 1.5 μg · l−1 · 6 h−1, P = 0.03), especially after administration of exogenous insulin (81.5 ± 6.4 vs. 99.3 ± 5.6 ng/l, P = 0.02). CONCLUSIONS—Vildagliptin lowers postprandial glucose concentrations by stimulating insulin secretion and suppressing glucagon secretion but not by altered insulin action or glucose effectiveness. A novel observation is that vildagliptin alters α-cell responsiveness to insulin administration, but the significance of this action is as yet unclear.
Gender-Related Difference in Left Ventricular Diastolic Elastance During Exercise in Patients With Diabetes Mellitus
Ha, Jong‐Won , Park, Sungha , Choi, Eui‐Young , Seo, Hye-Sun, Shim, Chi Young , Ahn, Jeong‐Ah , Lee, Se-Wha, Rim, Se‐Joong , Oh, Jae K. , Chung, Namsik, Lee, Hyun‐Chul , Kim, Jin‐Man

Mayo Clinic

Circulation Journal | August 25, 2008 | Volume: 72 | Issue: 9 | Pages: 1443-1448

10.1253/circj.cj-07-1028 | PMID 18724019 Get It

Idiopathic Nonspecific Interstitial Pneumonia
Hunninghake, Gary W., King, Talmadge E. , Lynch, David A. , Colby, Thomas V. , Galvin, Jeffrey R. , Brown, Kevin M. , Chung, Man Pyo , Cordier, Jean-François, Bois, Roland M. du, Flaherty, Kevin R., Franks, Teri J. , Hansell, David M., Hartman, Thomas E. , Kazerooni, Ella A. , Kim, Dong Soon, Kitaichi, Masanori, Koyama, Takashi , Nagai, Sonoko, Midthun, David E. , Müller, Nestor L., Raghu, Ganesh , Selman, Moisés , Wells, Athol U. , Travis, William D. , Flaherty, Kevin R., Martínez, Fernando J. , Nicholson, Andrew G.

Mayo Clinic

American Journal of Respiratory and Critical Care Medicine | April 3, 2008 | Volume: 177 | Issue: 12 | Pages: 1338-1347

10.1164/rccm.200611-1685oc | PMID 18388353 Get It

Abstract Rationale The 2002 American Thoracic Society/European Respiratory Society classification of idiopathic interstitial pneumonias identified nonspecific interstitial pneumonia (NSIP) as a provisional diagnosis. Concern was expressed that NSIP was a “wastebasket” category, difficult to distinguish from other idiopathic interstitial pneumonias. Objectives The following questions were addressed: (1) Is idiopathic NSIP a distinct entity? 2) If so, what are its clinical, radiologic and pathologic characteristics? (3) What is the role of radiology and pathology in establishing the diagnosis? (4) To make a diagnosis of idiopathic NSIP, what other disorders need to be excluded and how should this be done? Methods Investigators who had previously reported cases of idiopathic NSIP were invited to submit cases for review (n = 305). After initial review, cases with complete clinical, radiologic, and pathologic information (n = 193) were reviewed in a series of workshops. Measurements and Main Results Sixty-seven cases were identified as NSIP. Mean age was 52 years, 67% were women, 69% were never-smokers, and 46% were from Asian countries. The most common symptoms were dyspnea (96%) and cough (87%); 69% had restriction. By high-resolution computed tomography, the lower lung zones were predominantly involved in 92% of cases; 46% had a peripheral distribution; 47% were diffuse. Most showed a reticular pattern (87%) with traction bronchiectasis (82%) and volume loss (77%). Lung biopsies showed uniform thickening of alveolar walls with a spectrum of cellular to fibrosing patterns. Five-year survival was 82.3%. Conclusions Idiopathic NSIP is a distinct clinical entity that occurs mostly in middle-aged women who are never-smokers. The prognosis of NSIP is very good.
Time Course of Recovery of Left Ventricular Filling Pressure After Exercise in Healthy Subjects
Ha, Jong‐Won , Choi, Eui‐Young , Choi, Donghoon , Park, Sungha , Shim, Chi Young , Lee, Ji Hyun , Kim, Jin‐Man , Ahn, Jeong‐Ah , Lee, Se-Wha, Oh, Jae K. , Chung, Namsik

Mayo Clinic

Circulation Journal | January 30, 2008 | Volume: 72 | Issue: 2 | Pages: 186-188

10.1253/circj.72.186 | PMID 18219151 Get It

A 23-year-old man with seizures and visual deficit
Boustany, Rose-Mary N., Parisi, Joseph E., Boustany, Rose‐Mary , Britton, Jeffrey W. , Keegan, B. Mark

Mayo Clinic

Neurology | December 31, 2007 | Volume: 70 | Issue: 1 | Pages: 73-78

10.1212/01.wnl.0000298372.36118.1f | PMID 18166709 Get It

Thromboangiitis Obliterans (Buerger's Disease) in an Elderly Man After Cessation of Cigarette Smoking — A Case Report
Lie, J. T.

Mayo Clinic

Angiology | November 26, 2007 | Volume: 38 | Issue: 11 | Pages: 864-867

10.1177/000331978703801110 | PMID 3688555 Get It

Thromboangiitis obliterans (Buerger's disease) is an occlusive vascular disease that occurs almost exclusively in young male tobacco users. A unique case is documented here in which Buerger's disease affecting the upper limbs was diagnosed in a sixty-two-year-old man who was a cigarette smoker but had stopped smoking fifteen years earlier.
A 54-year-old man with slowness of movement and confusion
Geschwind, Michael D. , Josephs, Keith A. , Parisi, Joseph E., Keegan, B. Mark

Mayo Clinic

Neurology | November 5, 2007 | Volume: 69 | Issue: 19 | Pages: 1881-1887

10.1212/01.wnl.0000290370.14036.69 | PMID 17984457 Get It

A 75-year-old man with cognitive impairment and gait changes
Lippa, Carol F. , Parisi, Joseph E. , Boeve, Bradley F. , Keegan, B. Mark

Mayo Clinic

Neurology | September 10, 2007 | Volume: 69 | Issue: 11 | Pages: 1183-1189

10.1212/01.wnl.0000284706.20956.c7 | PMID 17846418 Get It

A 52-year-old man with progressive left-sided weakness and white matter disease
Fleming, John O., Parisi, Joseph E., Keegan, B. Mark

Mayo Clinic

Neurology | August 6, 2007 | Volume: 69 | Issue: 6 | Pages: 600-606

10.1212/01.wnl.0000279155.34707.b1 | PMID 17679680 Get It